Skip to main content
. 2017 Sep 8;7:11006. doi: 10.1038/s41598-017-11212-1

Figure 6.

Figure 6

Gal-1 induces PDGF- and TGF-β-like signals through the NRP-1/PDGF receptor (PDGFR) and NRP-1/TGF-β receptor (TGF-βR) complex. (A) Gal-1 induced PDGF and TGF-β-like signaling in Gal-1 silencing cells (LX-2-shB09 cells). (B) Knockdown of NRP-1 suppressed Gal-1-induced signaling. LX-2 cells were serum-starved for 24 h followed by Gal-1 (500 nM) treatment for 10 min. The cell lysate was collected for Western blotting. (C) Sorafenib and SIS3 (a tyrosine kinase and a TGF-βR inhibitor) suppressed Gal-1-induced hepatic stellate cell (HSC) migration. For the migration assay, LX-2 cells were pretreated with sorafenib and SIS3 for 1 h. Then, cells were suspended and seeded into a transwell. After incubation for 24 h, migrated cells were counted, and results are presented as the mean ±SEM of three independent experiments. *p < 0.05. (D) Knockdown of PDGFRβ suppressed Gal-1-induced hepatic stellate cell (HSC) migration. LX-2 cells were transfected with control (si-C) and PDGFRβ siRNA (si-PDGFRβ). The cells were treated with Gal-1 and the migration ability was measured.